Agent Orange and Pancreatic Cancer 

Pancreatic cancer is a presumptive condition for qualifying veterans exposed to burn pits or radiation, but Vietnam War veterans with Agent Orange exposure and others who are not covered by a VA presumption still have to establish service connection to receive benefits. Several paths to winning VA disability are possible, through medical evidence linking the cancer directly to military service, or through a service-connected condition such as Type 2 diabetes.

When Is Pancreatic Cancer a Presumptive VA Disability?

Pancreatic cancer is not presumed to be caused by Agent Orange under VA’s herbicide regulation. A veteran cannot establish a pancreatic cancer claim from qualifying Vietnam-era service alone. The record still needs medical evidence supporting direct service connection or secondary service connection through a disability VA has already recognized.

Pancreatic cancer is, however, a presumptive condition for burn pits and other airborne hazards (thanks to the PACT Act) and for ionizing radiation.

How Does VA Rate Pancreatic Cancer?

VA rates active pancreatic cancer at 100 percent under Diagnostic Code 7343 in the digestive-system rating schedule. The 100% rating continues while the cancer is active and beyond the end of surgery, radiation, chemotherapy, or another therapeutic procedure. Six months after treatment is discontinued, VA must conduct an examination and determine the appropriate rating.

What Does VA Rate After Cancer Treatment Ends?

If there has been no local recurrence or metastasis, VA rates the remaining disabilities. Depending on the medical record, those residuals may involve digestive impairment, weight loss, diabetes after pancreatic surgery, or other functional effects documented by the treating specialists.

What Evidence Is Needed for a Pancreatic Cancer Claim?

• Diagnosis and primary site: Include the biopsy or surgical pathology report, imaging, staging workup, and oncologist’s records. These documents should identify the cancer and distinguish a primary pancreatic malignancy from cancer that metastasized to the pancreas.
• Treatment dates and residuals: Submit surgery, chemotherapy, and radiation records, including the date treatment ended. These dates affect the 100 percent rating and the mandatory examination under § 4.114.
• Exposure evidence: Include the service records that establish qualifying service or actual toxic exposure. Presumed exposure to Agent Orange does not establish a presumption for pancreatic cancer.
• A reasoned nexus opinion: The physician should review the service and medical records, use the “at least as likely as not” standard, identify whether the opinion supports direct causation, secondary causation, or aggravation, and explain the conclusion. Language such as “may be related” or “cannot be ruled out” is too speculative to establish the nexus by itself.
• Analysis of other risk factors: A persuasive opinion addresses smoking, obesity, family history, alcohol use, diabetes, and any other material risk factors in the veteran’s record. Ignoring a known risk factor gives VA an obvious reason to favor a competing opinion.
• Lay and buddy statements: These statements can describe the circumstances of exposure, symptom history, and effects on work or daily life. Medical causation still requires competent medical evidence.

A specialist’s explanation can outweigh a boilerplate negative opinion. In a landmark case on appeal from the VA Regional Office of Wilmington, Delaware (Board of Veterans’ Appeals decision No: 1510983, March 16, 2015), a private oncologist’s reasoned opinion regarding a veteran’s adenocarcinoma of the pancreas allowed the veteran’s widow to win the legal battle that granted her late husband service-connected disability benefits.

Proving the Link Between Agent Orange and Pancreatic Cancer

Current scientific evidence has not definitively concluded that Agent Orange exposure causes pancreatic cancer such that VA would place it on the presumptive list. In Veterans and Agent Orange: Update 11 (2018), the National Academies placed pancreatic cancer in the category “inadequate or insufficient evidence to determine an association”.

However, it is possible to get medical opinions on causation, and there is medical literature that can support it. Agent Orange was contaminated with TCDD, a dioxin the EPA classifies as a probable human carcinogen, according to the American Cancer Society’s Agent Orange summary. A physician may consider that information when evaluating an individual veteran’s exposure and medical history, even if the general classification by itself is not sufficient for presumptive service connection. Veterans must either make the case for Agent Orange exposure directly contributing to their pancreatic cancer, or rely on secondary service connection.

Direct and Secondary Service Connection for Pancreatic Cancer

Direct service connection under 38 C.F.R. § 3.303 requires a current pancreatic cancer diagnosis, an in-service event or exposure, and competent medical evidence connecting the two. For qualifying Vietnam-era and other covered service, herbicide exposure may be presumed under 38 C.F.R. § 3.307(a)(6). Presumed exposure satisfies the in-service element. Because pancreatic cancer itself is not presumed, the veteran still needs a medical nexus opinion addressing why the cancer is at least as likely as not related to that exposure.

Medical literature supports a physician’s analysis, but a stack of articles is not a substitute for an opinion applying that research to the veteran’s history. If a treating oncologist will not provide the opinion, an independent specialist may review the record and address the nexus question. The evidence should address each legal element and give the medical expert enough detail to explain the individual connection.

BVA Citation 22017407, decided March 25, 2022, illustrates a successful direct theory. On readjudication after a Joint Motion for Remand, the Board granted service connection for pancreatic cancer due to herbicide and asbestos exposure. It credited a board-certified oncologist’s reasoned opinion over a VA examiner’s opinion whose rationale weakened its conclusion.

Claiming Pancreatic Cancer as Secondary to Agent Orange Diabetes

Pancreatic cancer can be service connected as secondary to service-connected Type 2 diabetes (which is presumed for qualifying herbicide exposure). The Agent Orange presumption establishes the connection for diabetes, while medical evidence must connect the diabetes to the pancreatic cancer.

A secondary claim will require evidence of the service-connected diabetes, the pancreatic cancer diagnosis, and a medical opinion linking the conditions. Aggravation is also an option: a medical opinion may support service connection by explaining that diabetes worsened the cancer, even if it did not cause it.

The Makhoul, Yacoub, and Siegel 2016 Veterans Administration registry study reported an adjusted hazard ratio of 2.17 for pancreatic cancer among subjects with Type 2 diabetes compared with matched diabetes-free controls. The 95 percent confidence interval was 1.70 to 2.77. Those findings support the possibility of an association between diabetes and pancreatic cancer.

BVA Citation 22013015, decided March 8, 2022, shows the secondary route in practice. The Board granted service connection for pancreatic cancer after a VA examiner explained that medical literature associated long-term Type 2 diabetes with a 1.5-fold to 2-fold increase in pancreatic cancer risk.

How Often Are Agent Orange Pancreatic Cancer Claims Granted?

Hill & Ponton’s analysis of Board of Veterans’ Appeals decisions from 2021 through 2026 (as of September 14, 2026) identified 361 decisions where an Agent Orange or herbicide-exposure theory was claimed or adjudicated for pancreatic cancer. Note that the Board of Veterans’ Appeals only decides on a fraction of all VA claims, usually the most complex and disputed.

What Do Granted Decisions Have in Common?

Grants in the screened set typically paired conceded or presumed herbicide exposure with a veteran-specific favorable medical opinion. The opinion addressed competing risk factors and explained either a direct nexus or a secondary chain through service-connected diabetes or chronic pancreatitis. Examples include BVA Citation 19109579, BVA Citation A22000695, and BVA Citation A25070607.

Why Are Pancreatic Cancer Claims Remanded?

In Board of Veterans’ Appeals decisions, remands frequently follow an inadequate medical opinion. Recurring problems include relying only on pancreatic cancer’s absence from the presumptive list, failing to address direct causation, overlooking favorable literature or a private opinion, confusing primary and metastatic disease, or failing to address causation and aggravation separately under a secondary theory.

For example, the case of a Vietnam veteran with pancreatic cancer (BVA Citation 21051018) was sent back to determine if the pancreatic cancer was related to his period of military service.

Why Are Pancreatic Cancer Claims Denied?

Hill & Ponton’s analysis of Board of Veterans’ Appeals decisions found that denials often involved unproven exposure, no competent nexus opinion, or an opinion using speculative language such as “may” or “could.” Other records contained a negative VA opinion that discussed smoking, obesity, family history, or another individual risk factor more fully than the favorable evidence did. Examples include BVA Citation A21002657 and BVA Citation 22007802.

Common Denial Reasons

• VA relies only on pancreatic cancer’s non-presumptive status. Absence from the herbicide list does not resolve direct service connection. An appeal can request an opinion that addresses the veteran’s actual exposure, medical history, and individual diagnosis.
• The medical opinion is speculative or conclusory. A statement that Agent Orange “may” have caused the cancer does not supply the required case-specific reasoning by itself. A specialist must use the correct standard and explain how the facts and literature support the conclusion.
• The examiner does not address competing risk factors. An oncologist’s opinion should discuss the risk factors present in the record and explain why service exposure or a service-connected condition remains at least as likely as not a cause or aggravating factor.
• The secondary theory was not developed. A claim framed only as an Agent Orange presumptive claim may omit the link through service-connected Type 2 diabetes or another service-connected condition. A medical opinion should address causation and aggravation separately under § 3.310.
• VA confuses primary pancreatic cancer with metastatic disease. Pathology and oncology records should identify the primary site and explain whether the pancreatic finding is a primary tumor, metastasis, or another form such as PNET.
• A survivor receives a denial based only on presumptive status. This should be appealed, as a DIC claim may proceed through direct causation or through a service-connected condition that contributed substantially or materially to death.

Can a Survivor Get Benefits After a Veteran Dies of Pancreatic Cancer?

A surviving spouse, qualifying child, or dependent parent may receive Dependency and Indemnity Compensation when a service-connected disability was the principal or a contributory cause of death. The survivor may pursue a direct theory that links the fatal pancreatic cancer to herbicide exposure.

A survivor may also pursue a contributory theory based on another service-connected condition. For example, a chronic B-cell leukemia may be presumptive for qualifying herbicide exposure. The intermediate presumptive condition could support DIC even if VA never established that condition during the veteran’s lifetime (but a medical opinion has to connect it to the veteran’s death).

Case Example: DIC for Pancreatic Cancer Through Service-Connected Diabetes

BVA Citation 1617930, decided May 4, 2016 is a successful appeal concerning a veteran who served in Vietnam and later died of pancreatic cancer. The surviving spouse’s theory used Type 2 diabetes as the intermediate condition (which was not service connected during the veteran’s life, but qualified for the herbicide presumption and was established inside the DIC claim).

A physician board certified in internal medicine, endocrinology, and metabolism addressed the veteran’s metabolic syndrome, including morbid obesity, hypertension, dyslipidemia, and Type 2 diabetes. The Board found the evidence to be approximately balanced as to whether herbicide exposure caused the cancer or presumptively service-connected diabetes materially contributed to death, then granted the claim under the benefit-of-the-doubt rule.

Has the VA Denied You?

An Agent Orange pancreatic cancer claim can succeed, but qualifying exposure alone is not enough. A developed record identifies the exact malignancy, presents the direct and secondary theories supported by the facts, and includes a specialist’s opinion that addresses competing risk factors and explains the conclusion. Hill & Ponton’s Agent Orange lawyers represent veterans and survivors after VA has issued a decision, including denials, remands and rating disputes.